• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与两性霉素B引起的寒战(颤抖)相关的因素。

Factors related to amphotericin-B-induced rigors (shivering).

作者信息

Carney-Gersten P, Giuffre M, Levy D

机构信息

University of Washington School of Nursing, Seattle.

出版信息

Oncol Nurs Forum. 1991 May-Jun;18(4):745-50.

PMID:2067963
Abstract

Amphotericin-B is the only parenteral agent currently available to treat systemic fungal infections. Pyrogenesis, accompanied by severe shivering, is a distressing side effect. Possible risk factors of developing this reaction have not been reported. A case series was developed to document the occurrence and duration of shivering in patients who received amphotericin-B and to investigate whether these responses were associated with a diagnosis of diabetes mellitus, receipt of insulin or beta blockers, the amount of body fat content, an immunocompromised state, age, and gender. Medical records were reviewed and abstracted for patients who received 20 milligrams or more of amphotericin-B per day for at least 10 consecutive days between January 1, 1984, and September 1, 1988. Results indicated that a diagnosis of diabetes, insulin therapy, and advancing age were inversely associated with the amphotericin-B-induced rigors response. Shivering was noted to occur first at the test dose, with the percentage of patients who shivered increasing with each successive dose (this peaked at the fifth therapeutic dosage). Of the factors under study, only advancing age appeared to be related to the duration of shivering. It is possible that identification of the descriptive characteristics of amphotericin-B-induced rigors will facilitate the nursing care of patients who receive this treatment; it also may be an important first step in the identification of risk factors for this clinical complication.

摘要

两性霉素B是目前唯一可用于治疗全身性真菌感染的肠胃外用药。发热并伴有严重寒战是一种令人痛苦的副作用。尚未有关于发生这种反应的可能风险因素的报道。开展了一个病例系列研究,以记录接受两性霉素B治疗的患者寒战的发生情况和持续时间,并调查这些反应是否与糖尿病诊断、胰岛素或β受体阻滞剂的使用、体脂含量、免疫功能低下状态、年龄和性别有关。对1984年1月1日至1988年9月1日期间连续至少10天每天接受20毫克或更多两性霉素B治疗的患者的病历进行了回顾和摘要分析。结果表明,糖尿病诊断、胰岛素治疗和年龄增长与两性霉素B引起的寒战反应呈负相关。寒战首先在试验剂量时出现,寒战患者的百分比随着每次后续剂量的增加而增加(在第五次治疗剂量时达到峰值)。在所研究的因素中,只有年龄增长似乎与寒战持续时间有关。确定两性霉素B引起的寒战的描述性特征可能有助于对接受该治疗的患者进行护理;这也可能是识别这种临床并发症风险因素的重要第一步。

相似文献

1
Factors related to amphotericin-B-induced rigors (shivering).与两性霉素B引起的寒战(颤抖)相关的因素。
Oncol Nurs Forum. 1991 May-Jun;18(4):745-50.
2
Amphotericin B-induced shivering in patients with cancer: a nursing approach.两性霉素B诱发癌症患者寒战:一种护理方法。
Heart Lung. 1988 Jul;17(4):432-40.
3
Efficacy of nefopam for the prevention and treatment of amphotericin B-induced shivering.奈福泮用于预防和治疗两性霉素B所致寒颤的疗效。
Arch Intern Med. 1997 Jul 28;157(14):1589-92.
4
Effects of extremity wraps to control drug-induced shivering: a pilot study.
Nurs Res. 1990 Sep-Oct;39(5):280-3.
5
Control of febrile shivering during amphotericin B therapy.两性霉素B治疗期间发热性寒战的控制
Oncol Nurs Forum. 1990 Jul-Aug;17(4):521-4.
6
Factors related to amphotericin-B-induced rigors.与两性霉素B引起寒战相关的因素。
Oncol Nurs Forum. 1992 Apr;19(3):395.
7
Amphotericin B revisited: reassessment of toxicity.两性霉素B再审视:毒性的重新评估
Am J Med. 1990 May;88(5N):22N-27N.
8
[Liposomal amphotericin B in the treatment of severe fungal infections. Results of a clinical cohort trial].[脂质体两性霉素B治疗严重真菌感染。一项临床队列试验的结果]
Dtsch Med Wochenschr. 2007 Oct;132(40):2062-6. doi: 10.1055/s-2007-985641.
9
Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial).脂质体两性霉素B作为侵袭性霉菌感染的初始治疗:一项比较高负荷剂量方案与标准剂量的随机试验(AmBiLoad试验)
Clin Infect Dis. 2007 May 15;44(10):1289-97. doi: 10.1086/514341. Epub 2007 Apr 9.
10
Amphotericin B colloidal dispersion (Amphocil) vs fluconazole for the prevention of fungal infections in neutropenic patients: data of a prematurely stopped clinical trial.两性霉素B胶体分散体(安浮素)与氟康唑预防中性粒细胞减少患者真菌感染的疗效比较:一项提前终止的临床试验数据
Bone Marrow Transplant. 2000 Apr;25(8):879-84. doi: 10.1038/sj.bmt.1702243.